Schrödinger, Inc. announced today that it has received an additional investment of $20 million from Bill Gates. “Schrödinger has ambitious plans for expanding their software platform that will make drug discovery significantly more productive and efficient,” said Gates. Dr. Boris Nikolic, a Scientific Advisor to Mr. Gates, will join Schrödinger’s Board of Directors. “The success […]
WASHINGTON, D.C., – Ahead of an institutional investor and analyst meeting to be held in New York, Danaher Corporation (NYSE:DHR) reaffirmed the Company’s diluted net earnings per share from continuing operations guidance of $0.80 – $0.85 for the fourth quarter 2012 and $3.14 to $3.19 for the full year 2012. The Company anticipates that 2013 […]
NEW YORK — Enzo Biochem, Inc. (NYSE:ENZ) today reported results for the fiscal first quarter ended October 31, 2012. Recent highlights included: • Favorable patent infringement ruling in which the court awarded the Company $48.5 million and that could result in court awarded interest costs that could add multi-millions more. • The quarterly net loss […]
HOLLISTON, Mass., — Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that its wholly-owned subsidiary, Harvard Apparatus Regenerative Technology, Inc., filed a registration statement with the SEC for an initial public offering, or IPO, of Harvard Apparatus […]
LARKSPUR, Calif. — BioCision LLC, a developer of sample standardization tools and solutions for the life science research and clinical markets, today announced it has raised $2.5 million in new growth financing. The round was led by BroadOak Capital Partners and included participation from Research Corporation Technologies, Inc. Comprised of debt and equity investment, funding […]
BALTIMORE, MD — Circulomics Inc has been awarded two Small Business Innovative Research (SBIR) Phase I awards, totaling $800k over 2 years, to develop its Ligo-miR microRNA assay technology and PicoSep single molecule analysis instrument. These awards were made through the National Institutes of Health’s (NIH) SHIFT initiative. They foster the transformation of academic scientific […]
LANCASTER, CA , – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its first fiscal quarter of fiscal year 2013, ended November 30, 2012 (1QFY13). Ms. Momoko Beran, chief financial officer of Simulations Plus, stated, “In accordance with our policy […]
SAN DIEGO, CA, – Biomatrica, Inc., a leader in ambient temperature biostability technology, today announced the completion of $5 million in private financing. Biomatrica has developed SampleMatrix® technology which has pioneered recent innovations in ambient storage of biological samples, from purified DNA, RNA, and proteins to complex systems such as tissue, cell lines, biopsies and […]
LARKSPUR, Calif.– BioCision LLC, a developer of sample standardization tools and solutions for the life science research and clinical markets, today announced it has raised $2.5 million in new growth financing. The round was led by BroadOak Capital Partners and included participation from Research Corporation Technologies, Inc. Comprised of debt and equity investment, funding will […]
LARKSPUR, Calif. — BioCision LLC, a developer of sample standardization tools and solutions for the life science research and clinical markets, today announced it has raised $2.5 million in new growth financing. The round was led by BroadOak Capital Partners and included participation from Research Corporation Technologies, Inc. Comprised of debt and equity investment, funding […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
